Last Updated : February 4, 2016
Details
FilesGeneric Name:
Emtricitabine/tenofovir disoproxil fumarate
Project Status:
Complete
Therapeutic Area:
HIV-1 infection, pre-exposure prophylaxis
Manufacturer:
Gilead Sciences Canada Inc.
Call for patient/clinician input open:
Brand Name:
Truvada
Project Line:
Reimbursement Review
Project Number:
SR0479-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
HIV-1 infection, pre-exposure prophylaxis
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : February 4, 2016